The Deal
Saturday, November 21, 
9:40 pm

Entries tagged "biotech mergers"

Sullivan & Cromwell's Pagnani on biotech M&A

At The Deal LLC's Healthcare Dealmaking Symposium, attorney Keith Pagnani commented on how the dealmaking landscape for biotechs is changing.


Dealmaker sees healthcare M&A slowdown

Richard H. Stowe, general partner at Health Enterprise Partners, said the recession is taking its toll on healthcare and pharma mergers despite a few recent megadeals.


Fitch: ImClone an expensive pill for Lilly

Pharmaceutical company Eli Lilly and Co. made its biggest acquisition ever with its $6.5 billion cash deal to acquire biotech company ImClone Systems Inc. on Monday. But credit rating agency Fitch Ratings feels Eli Lilly is taking a risk that may warrant a possible credit rating downgrade....



Top tags

You have executed a tag search on Dealscape. On the left,you will find a comprehensive list of stories tagged "biotech mergers." Below are the most-popular tags for Dealscape. On the right of the page you will find a search box to dig deeper into our content.
The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.

More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

By Bradford P. Weirick and Joelle Khoury, Gibson Dunn

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

By Derek Watson, KPMG

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

By Robert Teitelman

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.